ALL in TYA: adding to the case for clinical trial enrollment

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • A UK study reported significant improvements in OS and risk for mortality in teenage and young adult (TYA) patients (aged 15-24 y) with acute lymphoblastic leukemia (ALL) taking part in a clinical trial.

Why this matters

  • Rates of TYAs with cancer enrolled in clinical trials...